Tesetaxel: Difference between revisions
Content deleted Content added
Updating {{drugbox}} (changes to verified and watched fields - added verified revid - updated 'StdInChI_Ref', 'StdInChIKey_Ref', 'CAS_number_Ref', 'Verifiedfields', 'verifiedrevid') per Chem/Drugbox validation (report [[Wikipedia talk:... |
template:Pmid -> template:Cite pmid per Wikipedia:Redirects for discussion/Log/2014 July 2#Template:Pmid, replaced: {{pmid → {{cite pmid using AWB |
||
Line 46: | Line 46: | ||
}} |
}} |
||
'''Tesetaxel''' ('''DJ-927''') is a drug being investigated for [[chemotherapy]] of various types of cancer, including [[breast cancer]],<ref>{{ClinicalTrialsGov|NCT01609127|Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer}}</ref> [[gastric cancer]],<ref>{{ClinicalTrialsGov|NCT01348009|Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer}}</ref> and other solid tumours.<ref>{{pmid|21547572}}</ref> |
'''Tesetaxel''' ('''DJ-927''') is a drug being investigated for [[chemotherapy]] of various types of cancer, including [[breast cancer]],<ref>{{ClinicalTrialsGov|NCT01609127|Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer}}</ref> [[gastric cancer]],<ref>{{ClinicalTrialsGov|NCT01348009|Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer}}</ref> and other solid tumours.<ref>{{cite pmid|21547572}}</ref> |
||
==References== |
==References== |
Revision as of 22:47, 12 July 2014
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
Chemical and physical data | |
Formula | C46H60FN3O13 |
Molar mass | 881.98 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Tesetaxel (DJ-927) is a drug being investigated for chemotherapy of various types of cancer, including breast cancer,[1] gastric cancer,[2] and other solid tumours.[3]
References
- ^ Clinical trial number NCT01609127 for "Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer" at ClinicalTrials.gov
- ^ Clinical trial number NCT01348009 for "Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer" at ClinicalTrials.gov
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 21547572, please use {{cite journal}} with
|pmid=21547572
instead.